ERBB2 and breast carcinoma: Growing evidence suggests that current pathological indicators (e.g., estrogen receptor (ER), progesterone receptor(PR), human epidermal growth factor receptor 2(HER2), Ki67, and grading) have limitations for predicting breast cancer prognosis (30).